GC
GILD icon

Gould Capital’s Gilead Sciences GILD Stock Holding History

Gould Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
12,259
+99
+0.8% +$13K 0.86% 38
2026
Q1 		$1.69M Sell
12,160
-1,226
-9% -$172K 1.03% 33
2025
Q4 		$1.64M Sell
13,386
-72
-0.5% -$8.75K 1.01% 33
2025
Q3 		$1.49M Buy
13,458
+131
+1% +$14.9K 0.92% 36
2025
Q2 		$1.48M Sell
13,327
-244
-2% -$26K 0.99% 32
2025
Q1 		$1.52M Sell
13,571
-2,126
-14% -$219K 1.06% 29
2024
Q4 		$1.45M Sell
15,697
-431
-3% -$38.8K 1.01% 32
2024
Q3 		$1.35M Buy
16,128
+2,927
+22% +$223K 0.89% 33
2024
Q2 		$906K Buy
13,201
+756
+6% +$50.5K 0.64% 42
2024
Q1 		$912K Buy
12,445
+1,802
+17% +$139K 0.64% 43
2023
Q4 		$862K Sell
10,643
-1,035
-9% -$80.5K 0.63% 41
2023
Q3 		$865K Buy
11,678
+817
+8% +$62.8K 0.7% 40
2023
Q2 		$837K Buy
10,861
+10,710
+7,093% +$854K 0.64% 41
2023
Q1 		$12.6K Buy
151
+51
+51% +$4.22K 0.01% 140
2022
Q4 		$8.59K Sell
100
-25
-20% -$1.98K 0.01% 152
2022
Q3 		$8K Buy
+125
New +$7.88K 0.01% 148

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gould Capital's GILD Position: Q2 2026 in Review

Gould Capital increased its Gilead Sciences (GILD) stake by 0.81% in Q2 2026, buying an estimated $13K and bringing the position to 12,259 shares worth $1.55M. The position accounts for 0.86% of the portfolio, ranked #38.

Gould Capital first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.69M in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Gould Capital held 12,259 shares of Gilead Sciences worth $1.55M as of Q2 2026.
  • Gould Capital bought 99 Gilead Sciences shares in Q2 2026, an estimated $13K.
  • Gilead Sciences made up 0.86% of Gould Capital's portfolio in Q2 2026, its #38 holding.
  • Gould Capital first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
  • Gould Capital's Gilead Sciences position peaked at $1.69M in Q1 2026.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gould Capital's 13F filing for Q2 2026, filed 7 Aug 2026.